Retatrutide vs Semaglutide & Tirzepatide: What to Know A new weight loss drug can sound exciting, especially when early results look powerful and many patients are asking the same question: Is retatrutide the next breakthrough after semaglutide and tirzepatideor is the online hype moving faster than the medical facts
During your consultation, be prepared to discuss : Your current diabetes control and any home blood glucose monitoring results Previous medication history and responses to different treatments Your breastfeeding intentions and duration goals Any family history of diabetes or metabolic conditions Lifestyle factors including diet, physical activity, and weight changes Your GP may arrange : HbA1c testing to assess overall glycaemic control Referral to a diabetes specialist nurse or consultant endocrinologist Dietitian consultation for medical nutrition therapy Postnatal diabetes review if you had gestational diabetes Remember that uncontrolled diabetes poses significant risks including cardiovascular disease, neuropathy, retinopathy, and nephropathy
GLP-1 Market Companies Novo Nordisk Eli Lilly and Company Zealand Pharma Structure Therapeutics Amgen Viking Therapeutics Sanofi AstraZeneca Hansoh Pharmaceutical Group Co
IMPORTANT NOTICE: NC Medicaid has updated coverage rules for certain weight management medications, including: Zepbound Wegovy Saxenda For those receiving Wegovy and Zepbound, providers will need to obtain a prior authorization for medication to be covered, but Saxenda will no longer be covered for any indications
